Farmasa
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Farmasa - overview
Established
1953
Location
Sao Paulo, -, Brazil
Primary Industry
Pharmaceuticals
About
Farmasa is an online pharmacy specializing in health and wellness products tailored to customer needs, offering a wide range of over-the-counter medications, dietary supplements, personal care items, and cosmetics. Farmasa, founded in 1953 in Sao Paulo, Brazil, operates as an online pharmacy providing health and wellness products. The company underwent a significant change in June 2008 when it merged with Hypermarcas SA. The founder, Marco Cecchini, has a history of establishing companies in the health sector.
The most recent funding round was a BUYOUT amounting to USD 139. 00 mn, raising a total of USD 139. 00 mn, with GP Investments as the investor. Farmasa operates as an online pharmacy, focusing on health and wellness products tailored for individual customer needs.
The company offers a broad range of products, including over-the-counter medications, dietary supplements, personal care items, and cosmetics, aiming to address various health issues such as seasonal illnesses, skin care, and overall wellness. Their offerings cater to a diverse customer base, including individuals seeking health solutions, families looking for pediatric products, and seniors requiring specialized care products. Farmasa serves markets primarily in Italy and has extended its reach across Europe, ensuring that products are accessible to a wider audience. The company's commitment to quality and service is reflected in the support provided by their team of licensed pharmacists, who assist customers in making informed decisions about their health products.
In the most recent year, 2007, Farmasa reported a revenue of USD 133,536,872. 30 and an EBITDA of USD 16,567,859. 10. The revenue model is structured around direct-to-consumer sales through their online platform, with fast shipping for orders exceeding EUR 39.
90 qualifying for free delivery. The extensive catalog includes over 60,000 references, with individual pricing and discounts to encourage customer engagement and repeat purchases. Farmasa's growth strategy includes launching new products designed to enhance their health and wellness offerings, although specific details on release dates are not provided. The company aims to expand its market presence in Europe by targeting additional countries for distribution.
The recent funding through the BUYOUT in June 2008 has provided the necessary capital to support these initiatives and facilitate the merger with Hypermarcas SA, thereby enhancing operational capabilities and market reach.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.farmasa.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Farmasa - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Placement/Follow on | Completed | Hypermarcas S.A. | - | ||||||||
| Merger | Completed | Farmasa | - | ||||||||
| Buyout | Completed | Farmasa | - |
Displaying 1 - 3 of 3

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.